121 related articles for article (PubMed ID: 23857176)
1. Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus.
Joglekar AV; Hollis RP; Kuftinec G; Senadheera S; Chan R; Kohn DB
Mol Ther; 2013 Sep; 21(9):1705-17. PubMed ID: 23857176
[TBL] [Abstract][Full Text] [Related]
2. Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.
Händel EM; Gellhaus K; Khan K; Bednarski C; Cornu TI; Müller-Lerch F; Kotin RM; Heilbronn R; Cathomen T
Hum Gene Ther; 2012 Mar; 23(3):321-9. PubMed ID: 21980922
[TBL] [Abstract][Full Text] [Related]
3. Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs.
Ellis BL; Hirsch ML; Porter SN; Samulski RJ; Porteus MH
Gene Ther; 2013 Jan; 20(1):35-42. PubMed ID: 22257934
[TBL] [Abstract][Full Text] [Related]
4. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses.
Mahesh S; Li J; Travieso T; Psaradelli D; Negri D; Klotman M; Cara A; Blasi M
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005931
[TBL] [Abstract][Full Text] [Related]
5. Efficient Nuclease-Directed Integration of Lentivirus Vectors into the Human Ribosomal DNA Locus.
Schenkwein D; Afzal S; Nousiainen A; Schmidt M; Ylä-Herttuala S
Mol Ther; 2020 Aug; 28(8):1858-1875. PubMed ID: 32504545
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.
Bona R; Michelini Z; Mazzei C; Gallinaro A; Canitano A; Borghi M; Vescio MF; Di Virgilio A; Pirillo MF; Klotman ME; Negri D; Cara A
Mol Ther Methods Clin Dev; 2021 Dec; 23():263-275. PubMed ID: 34729374
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity.
Lin YY; Belle I; Blasi M; Huang MN; Buckley AF; Rountree W; Klotman ME; Cara A; Negri D
Mol Ther Methods Clin Dev; 2020 Jun; 17():532-544. PubMed ID: 32258216
[TBL] [Abstract][Full Text] [Related]
8. Targeted genome editing in human repopulating haematopoietic stem cells.
Genovese P; Schiroli G; Escobar G; Tomaso TD; Firrito C; Calabria A; Moi D; Mazzieri R; Bonini C; Holmes MC; Gregory PD; van der Burg M; Gentner B; Montini E; Lombardo A; Naldini L
Nature; 2014 Jun; 510(7504):235-240. PubMed ID: 24870228
[TBL] [Abstract][Full Text] [Related]
9. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.
Hoban MD; Cost GJ; Mendel MC; Romero Z; Kaufman ML; Joglekar AV; Ho M; Lumaquin D; Gray D; Lill GR; Cooper AR; Urbinati F; Senadheera S; Zhu A; Liu PQ; Paschon DE; Zhang L; Rebar EJ; Wilber A; Wang X; Gregory PD; Holmes MC; Reik A; Hollis RP; Kohn DB
Blood; 2015 Apr; 125(17):2597-604. PubMed ID: 25733580
[TBL] [Abstract][Full Text] [Related]
10. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.
Wang X; Wang Y; Wu X; Wang J; Wang Y; Qiu Z; Chang T; Huang H; Lin RJ; Yee JK
Nat Biotechnol; 2015 Feb; 33(2):175-8. PubMed ID: 25599175
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectors.
Joglekar AV; Stein L; Ho M; Hoban MD; Hollis RP; Kohn DB
Hum Gene Ther; 2014 Jul; 25(7):599-608. PubMed ID: 24568341
[TBL] [Abstract][Full Text] [Related]
12. In vivo genome editing using Staphylococcus aureus Cas9.
Ran FA; Cong L; Yan WX; Scott DA; Gootenberg JS; Kriz AJ; Zetsche B; Shalem O; Wu X; Makarova KS; Koonin EV; Sharp PA; Zhang F
Nature; 2015 Apr; 520(7546):186-91. PubMed ID: 25830891
[TBL] [Abstract][Full Text] [Related]
13. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.
Chu VT; Weber T; Wefers B; Wurst W; Sander S; Rajewsky K; Kühn R
Nat Biotechnol; 2015 May; 33(5):543-8. PubMed ID: 25803306
[TBL] [Abstract][Full Text] [Related]
14. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.
Maruyama T; Dougan SK; Truttmann MC; Bilate AM; Ingram JR; Ploegh HL
Nat Biotechnol; 2015 May; 33(5):538-42. PubMed ID: 25798939
[TBL] [Abstract][Full Text] [Related]
15. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
Ran FA; Hsu PD; Lin CY; Gootenberg JS; Konermann S; Trevino AE; Scott DA; Inoue A; Matoba S; Zhang Y; Zhang F
Cell; 2013 Sep; 154(6):1380-9. PubMed ID: 23992846
[TBL] [Abstract][Full Text] [Related]
16. Studies of retroviral infection in humanized mice.
Marsden MD; Zack JA
Virology; 2015 May; 479-480():297-309. PubMed ID: 25680625
[TBL] [Abstract][Full Text] [Related]
17. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal.
Fares I; Chagraoui J; Gareau Y; Gingras S; Ruel R; Mayotte N; Csaszar E; Knapp DJ; Miller P; Ngom M; Imren S; Roy DC; Watts KL; Kiem HP; Herrington R; Iscove NN; Humphries RK; Eaves CJ; Cohen S; Marinier A; Zandstra PW; Sauvageau G
Science; 2014 Sep; 345(6203):1509-12. PubMed ID: 25237102
[TBL] [Abstract][Full Text] [Related]
18. Integrase-deficient lentivirus: opportunities and challenges for human gene therapy.
Liu KC; Lin BS; Gao AD; Ma HY; Zhao M; Zhang R; Yan HH; Yi XF; Lin SJ; Que JW; Lan XP
Curr Gene Ther; 2014; 14(5):352-64. PubMed ID: 25174579
[TBL] [Abstract][Full Text] [Related]
19. HIV eradication--from Berlin to Boston.
Cannon PM; Kohn DB; Kiem HP
Nat Biotechnol; 2014 Apr; 32(4):315-6. PubMed ID: 24714473
[No Abstract] [Full Text] [Related]
20. Correcting inborn errors of immunity: From viral mediated gene addition to gene editing.
Castiello MC; Ferrari S; Villa A
Semin Immunol; 2023 Mar; 66():101731. PubMed ID: 36863140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
